Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
25.82
+2.03 (8.53%)
Dec 20, 2024, 4:00 PM EST - Market closed
Monopar Therapeutics Employees
As of December 31, 2023, Monopar Therapeutics had 10 total employees, including 9 full-time and 1 part-time employees. The number of employees decreased by 2 or -16.67% compared to the previous year.
Employees
10
Change (1Y)
-2
Growth (1Y)
-16.67%
Revenue / Employee
n/a
Profits / Employee
-$647,473
Market Cap
136.27M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Akoya Biosciences | 330 |
| Protalix BioTherapeutics | 208 |
| Enanta Pharmaceuticals | 145 |
| InflaRx | 62 |
| Black Diamond Therapeutics | 54 |
| Achieve Life Sciences | 22 |
| Galectin Therapeutics | 14 |
| Atossa Therapeutics | 12 |
MNPR News
- 1 day ago - Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants - GlobeNewsWire
- 16 days ago - Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu - GlobeNewsWire
- 18 days ago - Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference - GlobeNewsWire
- 26 days ago - Monopar Therapeutics: Radiopharmaceuticals And Rare Disease Potential In Focus - Seeking Alpha
- 6 weeks ago - Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments - GlobeNewsWire
- 7 weeks ago - Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock - GlobeNewsWire
- 7 weeks ago - Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock - GlobeNewsWire
- 7 weeks ago - Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock - GlobeNewsWire